Financiación de medicamentos: Los aspectos jurídicos / Financing of drugs: legal aspects
An. R. Acad. Farm
; 79(2): 293-307, abr.-jun. 2013.
Article
in Spanish
| IBECS
| ID: ibc-114196
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
El derecho a la protección de la salud impulsa al poder ejecutivo a establecer una política sanitaria conducente, dentro de los principios de equidad, calidad y participación ciudadana, a la promoción del uso racional del medicamento y a adoptar medidas dirigidas a que la prestación farmacéutica, por el Sistema Nacional de Salud, se realice a precios razonables y con un gasto publico ajustado, dentro de la necesidad de optimizar los recursos disponibles. En la actualidad el Estado de Bienestar alcanzado en nuestro país se hace cada día más gravoso, de aquí que para garantizar la sostenibilidad del Sistema Nacional de Salud el Estado español haya promovido una reforma sanitaria a través de normas, entre otras, el Real Decreto Ley 16/ 2012 del cual analizamos el impacto y consecuencias más destacables en el sector farmacéutico
ABSTRACT
The right to health protection encourages the Executive to establish a leading health policy according to the principles of equity, quality and citizen participation, to promote a responsible use of drugs and to adopt measures in order to make the provision of pharmaceutical care affordable and with reasonable public health expenditure by the Spanish National Health System as part of the need of optimizing the available resources. Nowadays, the welfare state achieved in our V country is progressively more expensive. Hence, in order to guarantee the sustainability of the Spanish National Health System, the Spanish government has promoted a health reform through standards, among others the Royal Decree-]Law16/ 2012, of April 20, 2012. From this Royal Decree-] Law we analyze the impact and the most noteworthy consequences in the pharmaceutical sector
Search on Google
Collection:
National databases
/
Spain
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
Health problem:
Goal 11: Inequalities and inequities in health
/
Goal 4: Health financing
/
Target 3.8 Achieve universal access to health
Database:
IBECS
Main subject:
Drugs, Investigational
/
Chemistry, Pharmaceutical
/
Drug Monitoring
/
Drug and Narcotic Control
/
Legislation, Drug
Type of study:
Health economic evaluation
/
Prognostic study
Aspects:
Equity and inequality
Language:
Spanish
Journal:
An. R. Acad. Farm
Year:
2013
Document type:
Article
Institution/Affiliation country:
Real Academia Nacional de Farmacia/España
/
Universidad Complutense de Madrid/España